Objective: To investigate the relationship between quality of life
Introduction
Diseases such as RA are often characterized by the presence of autoantibodies. Rheumatoid factor is not specific for RA and may be present in patients with other diseases, such as hepatitis C, and in healthy older persons. Anti-citrullinated protein antibody "Anti CCP" is more specific for RA and may play a role in disease pathogenesis
(1&2)
. Approximately 50 to 80 percent of persons with RA have rheumatoid factor, anti-citrullinated protein anti-body, or both.Patients with RA may have a positive antinuclear antibody test result, and the test is of prognostic importance in juvenile forms of this disease, and both are components of new ACR 2010 criteria
(3)
.
The RA activity and the degree of joint damage are critical in the evolution of the dysfunction. They had been measured by objective instruments, like the American College of Rheumatism (ACR) response criteria and the disease activity score for 28 joints (DAS-28)
(4)
. The ACR criteria measure the difference between two evaluation moments in a patient using joint assessment, patient and physician global assessment,the health assessment questionnaire (HAQ)
(5)
Rheumatoid arthritis (RA) is a chronic, multi-systemic autoimmune and inflammatory disease, which can result in significant functional disability and depressive symptoms. These changes may have a negative influence on the performance of daily living and work activities, with consequent impact on the quality of life (QOL) (6) . Among the factors that could directly affect the reduction of QOL in patients with RA, depression deserves special attention. There was a close relationship between depression and the early stages of disability in patients with RA, and also that these patients became more depressed with the evolution of the disease
(7)
. Also the prevalence of depressive symptoms in patients with RA is of 33.7 and 53.2%, respectively
(8&9)
. Moreover, the Disease-specific instrument included to measure functional limitations, the HAQ in RA was closely correlated to the physical functioning dimension of the 36-item short form (36-SF) health survey, therefore SF-36 is considered a valid instrument for measuring physical functioning and comparing different aspects of HRQoL in patients with RA
(8)
Aim of the work:
The aim of this work was to investigate the relationship between quality of life (QOL), Anti-cyclic citrullinated peptide (Anti-CCP) and disease activity in patients with rheumatoid arthritis (RA). 
Patients and Methods:

Results
This study included 200 patients with rheumatoid arthritis fulfilled 2010 ACR/EULAR classification criteria, and 50 healthy as controls.
Table (1) shows demographic data in study & control groups. With nonsignificance difference in age, sex and marital status (P>0.05) comparing with control group.
Table (2) shows clinical data in study group. With (70.0%) of patients had Swelling, also (22.0%) had deformity, as regard there were (38.0%) of patients had symptoms limited mobility, also there were (48.0%) had constitutionals symptoms and there were (44.0%) of patients in study group had extra. Art. Manifestations. Mean value of diseases duration 1.79 years, also there were mean value of MS=27.0 minutes. As regard there (86.0%) of study group had pain. Fig (1) shows medications data in study group. With (46.0%) using Methoteraxat (MTX), (52.0%) using Leflunamide. As regard there were (26.0%) using Sulphasalazine, also (26.0%) of patients using systemic steroids and (62.0%) using NSAIDS. Table ( 3) shows laboratory data in study group with mean value of ESR 46.94mm/h with (50.0%) of patients had high ESR1hr. , also there were (71.0%) of patients positive RF and (32.0%) of patients had high DAS28-ESR.
Table (4) shows comparison of rheumatoid factor "RF", "Anti-CCP" , HAQ and SF-36 according disease activity in study group. With significance difference (P<0.05) in Anti-CCP and RF, and there were moderate significance difference (P<0.001) about HAQ & SF-36. Table (5) shows relation between clinical data and mean value HAQ in study group. There were moderate significance difference (P<0.001) between mean value of HAQ and pain, swelling, deformity, constitutionals symptoms and extra art. Manifestations. As regard there were highly significance difference (P<0.000) between mobility & mean value of HAQ. (11) showed that DAS28-ESR tends to produce higher values in women and long-term disease patients.
In present study there were highly significance difference (P<0.000) in rheumatoid arthritis cases. This agree with Salaffi, et al., (12) . Among several autoantibodies described in recent years in patients with RA, synthetic cyclic peptides containing citrulline CCP antibodies has been proposed as a new biomarker of disease severity .
Positivity of anti-CCP has been found in our and in several studies, to have prognostic properties in early (and very early) arthritis, although anti-CCP antibodies may not be present at disease manifestation but may develop later in a percentage of RA patients (13).
Klareskog et al
. (14) reported that anti-CCP antibodies detected in preclinical phases of RA predict a poor radiographic outcome in early RA after 2 years of follow-up, Kroot et al, (15) in a study of patients with early RA found that anti-CCP positive patients at follow up had developed significantly more radiographic damage than patients without this antibody. Similar to our results, Bukhari et al., (13) found that the presence of anti-CCP antibodies at baseline was strongly associated with both prevalent erosions (odds ratio [OR] 2.53]) and developing erosions at 5 years (OR 10.2).
Hence, continuous remission is the desired target state. A variety of response scores for RA patients based on clinical and serological data have been proposed and applied in clinical trials. Among these, the American College of Rheumatology (ACR) response criteria, which rely on a relative change of five core set variables, and the European League Against Rheumatism (EULAR) response criteria, which are based on an absolute change of the composite Disease Activity Score in 28 joints (DAS28) including the ACR/EULAR remission criteria, are most common
The anti-CCP antibody test is a useful diagnostic and prognostic tool in RA Shamala, et al., (16) Studies have consistently pointed out the role of this antibody as a strong predictor of joint erosions in RA.
In present study there were highly significance difference between DAS28-ESR & CRP this agree with Hansen et al., (17 ) who reported earlier studies frequently showed that seropositive RA with high titers of autoantibodies and high CRP values at diagnosis are associated with more destructive disease with poorer outcome.
In the present study, seropositivity and anti CCP, R.F was significantly less common in the subjective group. This indicates that patients in the subjective group had good prognosis in average, and there would not be a great need for treatment intensification; however, DAS28 was higher than 3.2. Papadopoulos et al (18) . In present study there were highly significance difference between pain, swelling, deformity and mobility with HAQ. This agree with Sharpeet al. observed that RA fatigue is a different phenomenon from normal tiredness because it is extreme, endless and unresolved described as an important and overwhelming complaint. Studies examining the predictive factors of fatigue in RA reported not only physical but also psychological and social aspects related to fatigue Yacoubet al. (19) assessed fatigue in 248 patients with RA, finding a prevalence of fatigue in approximately 90% and, in contrast to our results, a significant association with disease activity. Thyberget al. (20) suggested that disease activity is among the factors closely related to fatigue.
Conceptually, a generic QOL instrument, the SF-36, waschosen to enable comparison between the patient samples. However, the SF-36 has only a few items relevant to upper extremity function, an important disabling aspect in RA. The disease-specific instruments included to measure functional limitations, the Health Assessment Questionnaire (HAQ) in RA was closely correlated to the physical functioning dimension of the SF-36 (r =0.65) (21).
Our findings are in agreement with other studies from India and elsewhere. Similar to another study from India, Patients with RA were found to have greater reduction in QOL than those without Ex. RA
(22).
However, on multiple regression analysis only HAQ independently affected QOL. After controlling for the effect of HAQ, disease activity did not have an independent effect on QOL. Thus, although disease activity affects QOL, the predominant effect is through its influence on the functional disability of the patient.
We therefore conclude that the SF-36 is a valid instrument for measuring physical functioning and comparing different aspects of health related QOL in patients with RA. Moreover the SF-36 captures a wider range of disability in RA, in which comorbidity may also have an important role.
